TwinStrand Biosciences’ co-founder Jesse Salk has stepped down from the CEO role, according to a statement issued by the Seattle biotech company Friday. Salk will remain as chief scientific officer… Read More
New funding: Gene-sequencing startup TwinStrand Biosciences raised $50 million in a Series B round led by Section 32, a California-based fund focused on biotech, technology, healthcare and life sciences. Total… Read More
The greater Seattle area is a hotbed for health technology and the past year has seen groundbreaking advancements in the sector. So it’s little wonder that there’s stiff competition for… Read More
TwinStrand Biosciences, a Seattle startup developing next-generation DNA sequencing technology that promises to lead to early cancer detection, rapid identification of carcinogens and other breakthroughs, has raised $16 million in… Read More
TwinStrand Biosciences, a spin-out of the University of Washington, is raising cash to commercialize DNA sequencing technology that it says can detect tiny genetic mutations invisible to current sequencers.… Read More